Colossal
Colossal Biosciences is a pioneering biotechnology company focused on de-extinction, aiming to revive and reintroduce extinct species into their natural habitats through advanced genetic engineering technologies.
Status
Active
Category
BioTech
Total Funding
$435.0M
HQ
Dallas, TX
Founded
2021
About the company
Colossal Biosciences is a biotechnology and genetic engineering company pioneering the field of de-extinction. Utilizing advanced gene-editing technologies, including CRISPR, the company aims to revive extinct species such as the woolly mammoth, Tasmanian tiger, northern white rhinoceros, and the dodo. By focusing on species restoration, Colossal seeks to reintroduce these animals into their natural habitats, thereby contributing to ecosystem balance and combating climate change. The company's efforts also drive innovations in genetic engineering, conservation biology, and synthetic biology, with potential applications extending beyond de-extinction.
